TGFB1 and Hepatic fibrosis: Lee et al. observed that more than 50% patients undergoing treatment with metformin presented a regression of liver fibrosis [184], while other researchers demonstrated that metformin inhibited the expression of TGF-β, enhanced the phosphorylation of SMAD3 [185] and counteracted the activation of HSCs [186].